VYOME HOLDINGS, INC. Increase (Decrease) in Accounts Payable
VYOME HOLDINGS, INC. (HIND) reported Increase (Decrease) in Accounts Payable of -$33.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2021-05-12
- VYOME HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2021-03-31 was -$33.00K, a 107.82% decline year-over-year.
- VYOME HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2020-12-31 was -$41.00K, a 122.65% decline year-over-year.
- VYOME HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2020-09-30 was -$397.00K.
- VYOME HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2020-06-30 was -$17.00K.
- VYOME HOLDINGS, INC. increase (decrease) in accounts payable for fiscal 2020 was -$33.00K.
- VYOME HOLDINGS, INC. increase (decrease) in accounts payable for fiscal 2019 was -$543.00K, a 875.71% decline from fiscal 2018.
- VYOME HOLDINGS, INC. increase (decrease) in accounts payable for fiscal 2018 was $70.00K, a 88.78% decline from fiscal 2017.
- VYOME HOLDINGS, INC. increase (decrease) in accounts payable for fiscal 2017 was $624.00K, a 1256.52% increase from fiscal 2016.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$33.00K 10-Q · filed 2021-05-12 | -$74.00K derived: sum of 2 quarters · filed 2021-05-12 | -$471.00K derived: sum of 3 quarters · filed 2021-05-12 | -$488.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2020-12-31 | -$41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$438.00K derived: sum of 2 quarters · filed 2021-03-12 | -$455.00K derived: sum of 3 quarters · filed 2021-03-12 | -$33.00K 10-K · filed 2021-03-12 |
| 2020-09-30 | -$397.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$414.00K derived: sum of 2 quarters · filed 2020-11-06 | $8.00K 10-Q · filed 2020-11-06 | $189.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2020-06-30 | -$17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $405.00K 10-Q · filed 2020-07-30 | $586.00K derived: sum of 3 quarters · filed 2021-05-12 | $53.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2020-03-31 | $422.00K 10-Q · filed 2021-05-12 | $603.00K derived: sum of 2 quarters · filed 2021-05-12 | $70.00K derived: sum of 3 quarters · filed 2021-05-12 | $16.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $181.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$352.00K derived: sum of 2 quarters · filed 2021-03-12 | -$406.00K derived: sum of 3 quarters · filed 2021-03-12 | -$543.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | -$533.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$587.00K derived: sum of 2 quarters · filed 2020-11-06 | -$724.00K 10-Q · filed 2020-11-06 | -$789.00K derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | -$54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$191.00K 10-Q · filed 2020-07-30 | -$256.00K derived: sum of 3 quarters · filed 2020-07-30 | -$396.00K derived: sum of 4 quarters · filed 2020-07-30 |
| 2019-03-31 | -$137.00K 10-Q · filed 2020-06-19 | -$202.00K derived: sum of 2 quarters · filed 2020-06-19 | -$342.00K derived: sum of 3 quarters · filed 2020-06-19 | -$1.14M derived: sum of 4 quarters · filed 2020-06-19 |
| 2018-12-31 | -$65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$205.00K derived: sum of 2 quarters · filed 2020-02-27 | -$1.00M derived: sum of 3 quarters · filed 2020-02-27 | $70.00K 10-K · filed 2020-02-27 |
| 2018-09-30 | -$140.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$939.00K derived: sum of 2 quarters · filed 2019-11-08 | $135.00K 10-Q · filed 2019-11-08 | $225.00K derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | -$799.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $275.00K 10-Q · filed 2019-07-24 | $365.00K derived: sum of 3 quarters · filed 2019-07-24 | $841.00K derived: sum of 4 quarters · filed 2019-07-24 |
| 2018-03-31 | $1.07M 10-Q · filed 2019-05-10 | $1.16M derived: sum of 2 quarters · filed 2019-05-10 | $1.64M derived: sum of 3 quarters · filed 2019-05-10 | $1.48M derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | $90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $566.00K derived: sum of 2 quarters · filed 2019-02-22 | $407.00K derived: sum of 3 quarters · filed 2019-02-22 | $624.00K 10-K · filed 2019-02-22 |
| 2017-09-30 | $476.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $317.00K derived: sum of 2 quarters · filed 2018-11-02 | $534.00K 10-Q · filed 2018-11-02 | |
| 2017-06-30 | -$159.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $58.00K 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | $217.00K 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | $46.00K 10-K · filed 2018-03-05 | |||
| 2015-12-31 | $370.00K 10-K · filed 2018-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |